After listening to the Florida doctor--- yes, the Zager presentation is important and the results in Europe I hear have been good... this tech seems very important--- yes, my MD IR friend has said so always... Seems like this should be priority review and approval by FDA.--- we need good results in the trials for FDA approval; possible 2021 I hear... I’m not sure why this isn’t a buzz.--- Delcath history with FDA was not good and stock a disaster after $16--- as Sam knows, now is a new day. Should be a BUY now as a spec. Upside possible is great.
News 
Market Data 
Discover 
